CanBas CanBas (キャンバス) is a drug discovery company engaged in research and development of anti-cancer agents. | ||
Founding Date | Founding Date 2000 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US |
Employees | Employees 13 | Employees 82517% decrease |
Valuation ($) | Valuation ($) 109.6 m | Valuation ($) 648.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €535.2m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods €9.7m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit €534.4m (FY, 2024) |
Net income | Net income (¥1.2b) (FY, 2025) | Net income €162.2m (FY, 2024) |

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company